Ovid Therapeutics Inc (NASDAQ:OVID)
| 2.48 Delayed Data As of Jan 26 |  +0.08 / +3.33%Today’s Change | 1.41 Today|||52-Week Range 3.55 | +33.33% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Assets | Cash | 22.5M | 30.5M | 36.5M | 54.6M | |
| Short Term Investment Cash | -6.7M | 8.0M | 6.0M | 18.1M | ||
| Cash & Short Term Investments | 62.6M | 52.5M | 41.5M | 59.6M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 1.3M | |
| Inventories | Inventories | -- | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 2.6M | 2.7M | 2.8M | 1.9M | |
| Current Assets | 65.2M | 55.3M | 44.3M | 62.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 134.0K | 144.6K | 156.0K | 162.0K | |
| Depreciation | -66.3K | -76.5K | -86.2K | -95.9K | ||
| Intangible Assets | 313.3K | 406.1K | 391.9K | 331.0K | ||
| Other Assets | 3.4M | 5.1M | 3.3M | 3.8M | ||
| Total Assets | 68.6M | 60.4M | 47.6M | 66.7M | ||
| Liabilities | Accounts Payable | 3.4M | 4.6M | 3.8M | 4.4M | |
| Accrued Expenses | 2.4M | 3.6M | 2.3M | 2.3M | ||
| Other Current Liabilities | 2.4M | 3.6M | 2.3M | 2.3M | ||
| Other Liabilities | 7.5M | 10.4M | 8.8M | 8.1M | ||
| Total Liabilities | Other Liabilities | 0.00 | 0.00 | 0.00 | 1.3M | |
| Total Liabilities | 7.5M | 10.4M | 8.8M | 9.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 3.00 | ||
| Common Equity | 61.1M | 50.0M | 38.8M | 57.2M | ||
| Total Shareholder Equity | 61.1M | 50.0M | 38.8M | 57.2M | ||
| Share Information | Common Shares Outstanding | 24.6M | 24.7M | 24.7M | 38.7M | |
| Addtl. Info. | No data currently available for this section. | |||||
